US 11753381
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted A61KA61K31/40A61K31/4015
Quick answer
US patent 11753381 (Inhibitors of receptor interacting protein kinase I for the treatment of disease) held by The Board of Regents of the University of Texas System expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/40, A61K31/4015, A61K31/415, A61K31/4155